Enzalutamide

BDR Pharma launches patient-friendly prostrate cancer therapy – Times of India

[ad_1] BDR Pharma has introduced BDENZA (Enzalutamide), the world’s first oral solution, designed for the management of prostate cancer. BDENZA…